MétaCan
Menu
Back to cohort

O24 Durability of obeticholic acid response in PBC patients who did not achieve poise trial criteria

2021· article· en· W3184000324 on OpenAlexaff
Gideon M. Hirschfield, Marco Carbone, David Jones, Bettina E. Hansen, Andreas E. Kremer, Michael Trauner, A. Sender Liberman, Elizabeth Smott Malecha, Leigh MacConell, Jonty Manuja

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsUniversity of TorontoToronto Liver Centre
Fundersnot available
KeywordsObeticholic acidMedicineUrsodeoxycholic acidPlaceboClinical endpointInternal medicineGastroenterologyBilirubinDouble blindClinical trialSurrogate endpointSurgeryPathology

Abstract

fetched live from OpenAlex

Introduction In clinical studies and in clinical practice, response to primary biliary cholangitis (PBC) treatment has been assessed using dichotomous biochemical response criteria. Although achieving these criteria may be associated with improved clinical outcomes, the benefit in patients (pts) with an incomplete response to treatment may be underestimated. This analysis assessed the extent and durability of obeticholic acid (OCA) response in pts with PBC not achieving the dichotomous primary endpoint in the phase 3 POISE study through 72 months of OCA treatment. Methods Key inclusion criteria included PBC diagnosis, alkaline phosphatase (ALP) ≥1.67× upper limit of normal (ULN) and/or total bilirubin >ULN to <2× ULN, and on a stable dose of—or intolerant of—ursodeoxycholic acid (UDCA). During the 12-month double-blind (DB) phase, 216 pts were randomised to daily placebo, OCA 5–10 mg, or OCA 10 mg. This analysis pooled DB placebo (OCA baseline [BL] was open-label extension [OLE] day 0) and DB OCA pts to evaluate the efficacy and safety of up to 72 months of OCA treatment. Pts who achieved the POISE primary endpoint (ALP<1.67×ULN, with a ≥15% reduction from BL, and total bilirubin ≤ULN) 12 months from OCA BL were excluded. Values shown are mean (SD) unless otherwise specified. P values were based on paired t-tests. Results Of the 193 pts enrolled in the OLE, 107 (55%) did not achieve the POISE criteria after 12 months of OCA treatment. Pts were 93% female, 91% Caucasian, 56 (10) years old at BL, and 91% received UDCA (15 [4] mg/kg/day). At BL, ALP was 356 (138) U/L and total bilirubin was 13 (8) µmol/L (>ULN in 18 pts [17%]). Despite not achieving the POISE criteria after 12 months of OCA, a significant and durable reduction was observed in ALP (p<0.01 at all time points) through 72 months of treatment (figure 1). Total bilirubin levels remained stable and near BL values within the normal range through the duration of treatment. Throughout the 6-year study period, the most common adverse events were pruritus (92 pts [86%]) and fatigue (33 pts [31%]), consistent with previous reports from POISE and expected PBC symptoms. Conclusions Despite not achieving the POISE primary endpoint, these pts showed significant and sustained biochemical improvements.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.025

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.312
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same topicLiver Diseases and ImmunityFrench-language works237,207